“Father of Preventive Cardiology” Jeremiah Stamler Dies at 102

He was among the first to identify lifestyle factors that contribute to cardiovascular disease.

Written byLisa Winter
| 3 min read
Black and white photograph of Stamler looking into the camera.
Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Even after his 100th birthday came and went, Jeremiah Stamler remained committed to his research on lifestyle and other risk factors that lead to heart disease. He was one of the first to make connections between diet and heart health, leading to him being dubbed the “father of preventive cardiology.” On January 26, Stamler died at his home in Long Island at the age of 102.

Stamler was born to Russian immigrant parents in Brooklyn in 1919, though he grew up in New Jersey. His father was a dentist and his mother was a teacher. Stamler received his bachelor’s degree from Columbia University in 1940 and attended what is now known as SUNY Downstate Health Sciences University in Brooklyn for his medical degree, graduating in 1943. After completing his residency at a nearby hospital, Stamler joined the US Army as a radiologist and worked primarily in Bermuda at the end ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Lisa joined The Scientist in 2017. As social media editor, some of her duties include creating content, managing interactions, and developing strategies for the brand’s social media presence. She also contributes to the News & Opinion section of the website. Lisa holds a degree in Biological Sciences with a concentration in genetics, cell, and developmental biology from Arizona State University and has worked in science communication since 2012.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies